These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25510803)

  • 21. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
    Chen R; Cohen AL; Colman H
    Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-grade gliomas -- current concepts.
    Schramm J; Blümcke I; Ostertag CB; Schlegel U; Simon M; Lutterbach J
    Zentralbl Neurochir; 2006 May; 67(2):55-66. PubMed ID: 16673237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients with primary brain tumors.
    Behrend SW
    Oncol Nurs Forum; 2014 May; 41(3):335-6. PubMed ID: 24769600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant gliomas.
    Burton EC; Prados MD
    Curr Treat Options Oncol; 2000 Dec; 1(5):459-68. PubMed ID: 12057153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas.
    Soffietti R; Rudà R; Bradac GB; Schiffer D
    Neurosurgery; 1998 Nov; 43(5):1066-73. PubMed ID: 9802850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945.
    Fouladi M; Hunt DL; Pollack IF; Dueckers G; Burger PC; Becker LE; Yates AJ; Gilles FH; Davis RL; Boyett JM; Finlay JL
    Cancer; 2003 Sep; 98(6):1243-52. PubMed ID: 12973849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tailored therapy in diffuse gliomas: using molecular classifiers to optimize clinical management.
    Taylor JW; Chi AS; Cahill DP
    Oncology (Williston Park); 2013 Jun; 27(6):504-14. PubMed ID: 23909061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does chemotherapy benefit the patient with a central nervous system glioma?
    Rodriguez LA; Levin VA
    Oncology (Williston Park); 1987 Nov; 1(9):29-36, 40-1. PubMed ID: 3079493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Procarbazine--a traditional drug in the treatment of malignant gliomas.
    Goerne R; Bogdahn U; Hau P
    Curr Med Chem; 2008; 15(14):1376-87. PubMed ID: 18537615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy in low-grade gliomas.
    Viaccoz A; Lekoubou A; Ducray F
    Curr Opin Oncol; 2012 Nov; 24(6):694-701. PubMed ID: 22913972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Radiation Therapy Alone and Chemotherapy Alone for Low-Grade Gliomas without Surgical Resection.
    Wu J; Kim C; Bai HX; Tang L; Wang Y; Li X; Zhang Z; Karakousis G; Huang R; Zhang PJ; Xiao B; Yang L
    World Neurosurg; 2019 Feb; 122():e108-e120. PubMed ID: 30261385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic and prognostic value of alpha internexin expression in a series of 409 gliomas.
    Ducray F; Mokhtari K; Crinière E; Idbaih A; Marie Y; Dehais C; Paris S; Carpentier C; Dieme MJ; Adam C; Hoang-Xuan K; Duyckaerts C; Delattre JY; Sanson M
    Eur J Cancer; 2011 Mar; 47(5):802-8. PubMed ID: 21194923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delayed leptomeningeal and subependymal seeding after multiple surgeries for supratentorial diffuse low-grade gliomas in adults.
    Alvarez de Eulate-Beramendi S; Rigau V; Taillandier L; Duffau H
    J Neurosurg; 2014 Apr; 120(4):833-9. PubMed ID: 24286144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951.
    Gorlia T; Delattre JY; Brandes AA; Kros JM; Taphoorn MJ; Kouwenhoven MC; Bernsen HJ; Frénay M; Tijssen CC; Lacombe D; van den Bent MJ
    Eur J Cancer; 2013 Nov; 49(16):3477-85. PubMed ID: 23896377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Histological and molecular classification of gliomas].
    Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
    Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study of the effectiveness and safety of combined procarbazine, lomustine, and vincristine as a therapeutic method for recurrent high-grade glioma: A protocol for systematic review and meta-analysis.
    Cai Y; Jiang YG; Wang M; Jiang ZH; Tan ZG
    Medicine (Baltimore); 2020 Sep; 99(38):e22238. PubMed ID: 32957367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of the treatment of children with recurrent gliomas with lomustine and vincristine.
    Lefkowitz IB; Packer RJ; Sutton LN; Siegel KR; Bruce DA; Evans AE; Schut L
    Cancer; 1988 Mar; 61(5):896-902. PubMed ID: 3338054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upfront chemotherapy with CCNU alone for adults' low-grade gliomas: a clinical analysis.
    Kaloshi G; Rroji A; Petrela M
    J Neurooncol; 2014 Apr; 117(2):373-4. PubMed ID: 24473684
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemotherapy for malignant gliomas.
    Kyritsis AP
    Oncology (Williston Park); 1993 Sep; 7(9):93-100; discussion 103, 106. PubMed ID: 8217533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histone H1.0--a potential molecular marker with prognostic value for patients with malignant gliomas.
    Gabrovsky N; Georgieva M; Laleva M; Uzunov K; Miloshev G
    Acta Neurochir (Wien); 2013 Aug; 155(8):1437-42. PubMed ID: 23812966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.